We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Soft Supercapacitor Could Power Implantable Devices

By HospiMedica International staff writers
Posted on 28 Nov 2023

The field of bioelectronic devices is rapidly advancing, offering new possibilities for health monitoring and the treatment of diseases. More...

A critical aspect of these devices is their power source. Now, researchers have made a significant breakthrough by developing a novel way to power implantable devices using a supercapacitor. This technology differs from traditional batteries, which store chemical energy. Supercapacitors, on the other hand, store electrical energy directly, offering advantages in terms of flexibility and weight.

The soft, implantable supercapacitor that can power implantable devices was developed by a team of bioengineers from China in collaboration with researchers at Pennsylvania State University (University Park, PA, USA). In order to be used for powering implantable devices, a supercapacitor must be biodegradable as well as harmless to the patient as it degrades. The newly developed soft, implantable supercapacitor is unique because every component is biodegradable and safe for the patient as it breaks down. The design includes a zinc foil as the anode, molybdenum sulfide as the cathode, and an alginate gel serving as the electrolyte. For wireless charging, a magnesium coil is placed on the skin above where the supercapacitor is implanted in the body.

Prior to its application, the supercapacitor underwent rigorous testing to ensure its degradation remained within safe health limits. It was then paired with a previously developed implantable medication dispenser, also biodegradable, for a practical test. The combined device was implanted in mice with fever induced by yeast infections. The medication was dispensed by the device, leading to a noticeable reduction in the severity of the fevers in the mice treated. While these initial results are promising, the researchers recognize that further work is needed before this technology is ready for human use. For instance, they have yet to develop a mechanism to deactivate the supercapacitor after its intended use. This highlights the ongoing journey in bioelectronics towards creating efficient, safe, and patient-friendly implantable devices.

Related Links:
Pennsylvania State University


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.